HomeFile

File

View Category
Highlighted Presentations

SOLACI-SBHCI 2023 | Alternative Vascular Access for Structural Heart Interventions – Dr. Diego Silveira da Costa

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Diego...
solaci -
Learn More
Chronic Ischemic cardiopathy

Long Term Outcomes after Complex PCI According to Operator Experience and Use of IVUS

The use of intravascular ultrasound (IVUS) to guide percutaneous coronary interventions (PCI) has been shown to reduce...
solaci -
Learn More
Structural heart disease

bRight: Impact and Safety of the TriClip Device in a Real-World Cohort

The clinical importance of severe tricuspid regurgitation (TR) has been underestimated for many years now. However, studies...
solaci -
Learn More
Acute coronary syndromes

Crisis and Socioeconomic Disparities: Relationship with Recurrent Events After Myocardial Infarction

Socioeconomic status (SES) has been linked to recurrent atherosclerotic cardiovascular disease events (rASCVD) after myocardial infarction (MI)....
solaci -
Learn More
Chronic Ischemic cardiopathy

Are There Sex Differences in pLVAD-Assisted High Risk PCI?

The proportion of patients undergoing high risk PCI (HRPCI) is on the rise. It includes patients with...
solaci -
Learn More
Chronic Coronary Syndromes

EuroCTO: Safety and Benefit at 3 Years

Chronic total occlusions (CTOs) account for approximately 15-20% of patients with stable coronary artery disease. This field...
solaci -
Learn More
Structural heart disease

SCOPE I Results at 3 Years: ACURATE Neo vs. SAPIEN 3

Transcatheter aortic valve implantation (TAVI) has become the standard treatment for elderly patients with severe symptomatic aortic...
solaci -
Learn More
Acute coronary syndromes

STREAM-2: Reduced Dosage of Tenecteplase for Patients over 60 Years Old

Reduced dosage of tenecteplase in elderly patients undergoing a pharmaco-invasive strategy. Delays in achieving timely reperfusion in patients...
solaci -
Learn More